The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications
Abstract
Fibrosis denotes excessive scarring, which exceeds the normal wound healing response to injury in many tissues. Although the extracellular matrix deposition appears unstructured disrupting the normal tissue architecture and subsequently impairing proper organ function, fibrogenesis is a highly orchestrated process determined by defined sequences of molecular signals and cellular response mechanisms. Persistent injury and parenchymal cell death provokes tissue inflammation, macrophage activation and immune cell infiltration. The release of biologically highly active soluble mediators (alarmins, cytokines, chemokines) lead to the local activation of collagen producing mesenchymal cells such as pericytes, myofibroblasts or Gli1 positive mesenchymal stem cell-like cells, to a transition of various cell types into myofibroblasts as well as to the recruitment of fibroblast precursors. Clinical observations and experimental models highlighted that fibrosis is not a one-way road. Specific mechanistic principles of fibrosis regression involve the resolution of chronic tissue injury, the shift of inflammatory processes towards recovery, deactivation of myofibroblasts and finally fibrolysis of excess matrix scaffold. The thorough understanding of common principles of fibrogenic molecular signals and cellular mechanisms in various organs - such as liver, kidney, lung, heart or skin - is the basis for developing improved diagnostics including biomarkers or imaging techniques and novel antifibrotic therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Dulai, P. S., Singh, S., Patel, J., Soni, M., Prokop, L. J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., et al. (2017) · Hepatology · doi:10.1002/hep.29085 · Cited by 1,965
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.006 · Cited by 1,875
Marcellin, P., Gane, E., Buti, M., Afdhal, N., Sievert, W., Jacobson, I. M., Washington, M. K., Germanidis, G., Flaherty, J. F., Schall, R. A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61425-1 · Cited by 1,788
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649
The pathogenesis of cardiac fibrosis
Kong, P., Christia, P., & Frangogiannis, N. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1349-6 · Cited by 1,567
Mederacke, I., Hsu, C. C., Troeger, J. S., Huebener, P., Mu, X., Dapito, D. H., Pradere, J.-P., & Schwabe, R. F. (2013) · Nature Communications · doi:10.1038/ncomms3823 · Cited by 1,443
Fate Tracing Reveals the Pericyte and Not Epithelial Origin of Myofibroblasts in Kidney Fibrosis
Humphreys, B. D., Lin, S.-L., Kobayashi, A., Hudson, T. E., Nowlin, B. T., Bonventre, J. V., Valerius, M. T., McMahon, A. P., & Duffield, J. S. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090517 · Cited by 1,442
Liver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424
Self-citationHypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy
Marian, A. J., & Braunwald, E. (2017) · Circulation Research · doi:10.1161/circresaha.117.311059 · Cited by 1,403
Martinez, F. J., Collard, H. R., Pardo, A., Raghu, G., Richeldi, L., Selman, M., Swigris, J. J., Taniguchi, H., & Wells, A. U. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.74 · Cited by 1,388
Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair
Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M., & Cerami, A. (1994) · Molecular Medicine · doi:10.1007/bf03403533 · Cited by 1,308
Origin and function of myofibroblasts in kidney fibrosis
LeBleu, V. S., Taduri, G., O'Connell, J., Teng, Y., Cooke, V. G., Woda, C., Sugimoto, H., & Kalluri, R. (2013) · Nature Medicine · doi:10.1038/nm.3218 · Cited by 1,263
Immunology in the liver — from homeostasis to disease
Heymann, F., & Tacke, F. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.200 · Cited by 1,180
Self-citationReversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
Fioretto, P., Steffes, M. W., Sutherland, D. E. R., Goetz, F. C., & Mauer, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390202 · Cited by 1,135
Loomba, R., Seguritan, V., Li, W., Long, T., Klitgord, N., Bhatt, A., Dulai, P. S., Caussy, C., Bettencourt, R., Highlander, S. K., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.001 · Cited by 1,123
Leukocyte Behavior in Atherosclerosis, Myocardial Infarction, and Heart Failure
Swirski, F. K., & Nahrendorf, M. (2013) · Science · doi:10.1126/science.1230719 · Cited by 1,086
Fibroblasts in fibrosis: novel roles and mediators
Kendall, R. T., & Feghali-Bostwick, C. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00123 · Cited by 1,082
Identification and characterization of a fibroblast marker: FSP1.
Strutz, F., Okada, H., Lo, C. W., Danoff, T., Carone, R. L., Tomaszewski, J. E., & Neilson, E. G. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.2.393 · Cited by 1,077
Type 2 immunity in tissue repair and fibrosis
Gieseck, R. L., Wilson, M. S., & Wynn, T. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.90 · Cited by 1,055
Rock, J. R., Barkauskas, C. E., Cronce, M. J., Xue, Y., Harris, J. R., Liang, J., Noble, P. W., & Hogan, B. L. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117988108 · Cited by 1,030
Targeting hepatic macrophages to treat liver diseases
Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.026 · Cited by 1,003
Self-citationGenetics and epigenetics of NAFLD and NASH: Clinical impact
Eslam, M., Valenti, L., & Romeo, S. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.003 · Cited by 971
Willis, B. C., Liebler, J. M., Luby-Phelps, K., Nicholson, A. G., Crandall, E. D., du Bois, R. M., & Borok, Z. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62351-6 · Cited by 951
Perivascular Gli1+ Progenitors Are Key Contributors to Injury-Induced Organ Fibrosis
Kramann, R., Schneider, R. K., DiRocco, D. P., Machado, F., Fleig, S., Bondzie, P. A., Henderson, J. M., Ebert, B. L., & Humphreys, B. D. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2014.11.004 · Cited by 922
Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β
Abreu, J. G., Ketpura, N. I., Reversade, B., & De Robertis, E. M. (2002) · Nature Cell Biology · doi:10.1038/ncb826 · Cited by 902
Pathobiology of liver fibrosis: a translational success story
Lee, Y. A., Wallace, M. C., & Friedman, S. L. (2015) · Gut · doi:10.1136/gutjnl-2014-306842 · Cited by 894
Kawaguchi, M., Takahashi, M., Hata, T., Kashima, Y., Usui, F., Morimoto, H., Izawa, A., Takahashi, Y., Masumoto, J., Koyama, J., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.982777 · Cited by 884
Barry-Hamilton, V., Spangler, R., Marshall, D., McCauley, S., Rodriguez, H. M., Oyasu, M., Mikels, A., Vaysberg, M., Ghermazien, H., Wai, C., et al. (2010) · Nature Medicine · doi:10.1038/nm.2208 · Cited by 870
Hepatic lipocytes: the principal collagen-producing cells of normal rat liver.
Friedman, S. L., Roll, F. J., Boyles, J., & Bissell, D. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8681 · Cited by 859
Lin, S.-L., Kisseleva, T., Brenner, D. A., & Duffield, J. S. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080433 · Cited by 845
Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition
Zeisberg, M., Yang, C., Martino, M., Duncan, M. B., Rieder, F., Tanjore, H., & Kalluri, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700194200 · Cited by 839
Roles for chemokines in liver disease
Marra, F., & Tacke, F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.06.043 · Cited by 829
Self-citationMyofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Jiang, C., Benner, C., Iwaisako, K., Moore-Morris, T., Scott, B., Tsukamoto, H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201840109 · Cited by 805
Roles of TGF-beta in hepatic fibrosis
Gressner, A. M. (2002) · Frontiers in Bioscience · doi:10.2741/a812 · Cited by 783
Karlmark, K. R., Weiskirchen, R., Zimmermann, H. W., Gassler, N., Ginhoux, F., Weber, C., Merad, M., Luedde, T., Trautwein, C., & Tacke, F. (2009) · Hepatology · doi:10.1002/hep.22950 · Cited by 782
Self-citationBone marrow–derived progenitor cells in pulmonary fibrosis
Hashimoto, N., Jin, H., Liu, T., Chensue, S. W., & Phan, S. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18847 · Cited by 720
Gressner, A. M., & Weiskirchen, R. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00292.x · Cited by 718
Self-citationIdentification and isolation of a dermal lineage with intrinsic fibrogenic potential
Rinkevich, Y., Walmsley, G. G., Hu, M. S., Maan, Z. N., Newman, A. M., Drukker, M., Januszyk, M., Krampitz, G. W., Gurtner, G. C., Lorenz, H. P., et al. (2015) · Science · doi:10.1126/science.aaa2151 · Cited by 697
The immune system and kidney disease: basic concepts and clinical implications
Kurts, C., Panzer, U., Anders, H.-J., & Rees, A. J. (2013) · Nature Reviews Immunology · doi:10.1038/nri3523 · Cited by 696
Friedman, S. L., Ratziu, V., Harrison, S. A., Abdelmalek, M. F., Aithal, G. P., Caballeria, J., Francque, S., Farrell, G., Kowdley, K. V., Craxi, A., et al. (2018) · Hepatology · doi:10.1002/hep.29477 · Cited by 671
Self-citationVilar-Gomez, E., & Chalasani, N. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.013 · Cited by 610
Baeck, C., Wehr, A., Karlmark, K. R., Heymann, F., Vucur, M., Gassler, N., Huss, S., Klussmann, S., Eulberg, D., Luedde, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300304 · Cited by 609
Self-citationRole of Oxidative Stress and Molecular Changes in Liver Fibrosis: A Review
Sanchez-Valle, V., C. Chavez-Tapia, N., Uribe, M., & Mendez-Sanchez, N. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803341520 · Cited by 593
Noninvasive, Quantitative Assessment of Liver Fat by MRI‐PDFF as an Endpoint in NASH Trials
Caussy, C., Reeder, S. B., Sirlin, C. B., & Loomba, R. (2018) · Hepatology · doi:10.1002/hep.29797 · Cited by 563
Krenkel, O., Puengel, T., Govaere, O., Abdallah, A. T., Mossanen, J. C., Kohlhepp, M., Liepelt, A., Lefebvre, E., Luedde, T., Hellerbrand, C., et al. (2018) · Hepatology · doi:10.1002/hep.29544 · Cited by 557
Self-citationLoomba, R., Lawitz, E., Mantry, P. S., Jayakumar, S., Caldwell, S. H., Arnold, H., Diehl, A. M., Djedjos, C. S., Han, L., Myers, R. P., et al. (2018) · Hepatology · doi:10.1002/hep.29514 · Cited by 549
Circulating fibrocytes: collagen-secreting cells of the peripheral blood
Quan, T. E., Cowper, S., Wu, S.-P., Bockenstedt, L. K., & Bucala, R. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.10.005 · Cited by 528
Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update
Su, H., Lei, C.-T., & Zhang, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00405 · Cited by 524
Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice
Troeger, J. S., Mederacke, I., Gwak, G., Dapito, D. H., Mu, X., Hsu, C. C., Pradere, J., Friedman, R. A., & Schwabe, R. F. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.036 · Cited by 515
The good and the bad collagens of fibrosis – Their role in signaling and organ function
Karsdal, M. A., Nielsen, S. H., Leeming, D. J., Langholm, L. L., Nielsen, M. J., Manon-Jensen, T., Siebuhr, A., Gudmann, N. S., Rønnow, S., Sand, J. M., et al. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.014 · Cited by 509
Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis
Mchedlidze, T., Waldner, M., Zopf, S., Walker, J., Rankin, A. L., Schuchmann, M., Voehringer, D., McKenzie, A. N. J., Neurath, M. F., Pflanz, S., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.018 · Cited by 502
Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis
Grgic, I., Campanholle, G., Bijol, V., Wang, C., Sabbisetti, V. S., Ichimura, T., Humphreys, B. D., & Bonventre, J. V. (2012) · Kidney International · doi:10.1038/ki.2012.20 · Cited by 477
Endothelial–Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis
Hashimoto, N., Phan, S. H., Imaizumi, K., Matsuo, M., Nakashima, H., Kawabe, T., Shimokata, K., & Hasegawa, Y. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0031oc · Cited by 451
A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis☆
Forbes, S. J., Russo, F. P., Rey, V., Burra, P., Rugge, M., Wright, N. A., & Alison, M. R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.025 · Cited by 436
Keloids: The paradigm of skin fibrosis — Pathomechanisms and treatment
Andrews, J. P., Marttala, J., Macarak, E., Rosenbloom, J., & Uitto, J. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.01.013 · Cited by 433
Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases
Barnes, J. L., & Gorin, Y. (2011) · Kidney International · doi:10.1038/ki.2010.516 · Cited by 432
Hammel, P., Couvelard, A., O'Toole, D., Ratouis, A., Sauvanet, A., Fléjou, J. F., Degott, C., Belghiti, J., Bernades, P., Valla, D., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102083440604 · Cited by 427
Dulauroy, S., Di Carlo, S. E., Langa, F., Eberl, G., & Peduto, L. (2012) · Nature Medicine · doi:10.1038/nm.2848 · Cited by 418
Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
Rotman, Y., & Sanyal, A. J. (2017) · Gut · doi:10.1136/gutjnl-2016-312431 · Cited by 410
Boursier, J., Vergniol, J., Guillet, A., Hiriart, J.-B., Lannes, A., Le Bail, B., Michalak, S., Chermak, F., Bertrais, S., Foucher, J., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.023 · Cited by 400
Diagnosis and Quantitation of Fibrosis
Manning, D. S., & Afdhal, N. H. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.001 · Cited by 399
The big five in fibrosis: Macrophages, myofibroblasts, matrix, mechanics, and miscommunication
Pakshir, P., & Hinz, B. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.01.019 · Cited by 396
Role of Lung Pericytes and Resident Fibroblasts in the Pathogenesis of Pulmonary Fibrosis
Hung, C., Linn, G., Chow, Y.-H., Kobayashi, A., Mittelsteadt, K., Altemeier, W. A., Gharib, S. A., Schnapp, L. M., & Duffield, J. S. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201212-2297oc · Cited by 385
Sun, M., Chen, M., Dawood, F., Zurawska, U., Li, J. Y., Parker, T., Kassiri, Z., Kirshenbaum, L. A., Arnold, M., Khokha, R., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.643585 · Cited by 383
Immune mechanisms in pulmonary fibrosis
Kolahian, S., Fernandez, I. E., Eickelberg, O., & Hartl, D. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0121tr · Cited by 349
Role of inflammatory response in liver diseases: Therapeutic strategies
Campo, J. A. D., Gallego, P., & Grande, L. (2018) · World Journal of Hepatology · doi:10.4254/wjh.v10.i1.1 · Cited by 348
Jun, J.-I., & Lau, L. F. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93563 · Cited by 345
Lv, W., Booz, G. W., Wang, Y., Fan, F., & Roman, R. J. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.12.016 · Cited by 338
Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver
Österreicher, C. H., Penz-Österreicher, M., Grivennikov, S. I., Guma, M., Koltsova, E. K., Datz, C., Sasik, R., Hardiman, G., Karin, M., & Brenner, D. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017547108 · Cited by 337
Blockade of CCR2 Ameliorates Progressive Fibrosis in Kidney
Kitagawa, K., Wada, T., Furuichi, K., Hashimoto, H., Ishiwata, Y., Asano, M., Takeya, M., Kuziel, W. A., Matsushima, K., Mukaida, N., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63292-0 · Cited by 330
Reactive oxygen species and fibrosis: further evidence of a significant liaison
Richter, K., & Kietzmann, T. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2445-3 · Cited by 322
Forced Vital Capacity in Idiopathic Pulmonary Fibrosis — FDA Review of Pirfenidone and Nintedanib
Karimi-Shah, B. A., & Chowdhury, B. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500526 · Cited by 316
Targeting renal fibrosis: Mechanisms and drug delivery systems
Nastase, M. V., Zeng-Brouwers, J., Wygrecka, M., & Schaefer, L. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.12.019 · Cited by 302
Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice
Kovalovich, K., DeAngelis, R. A., Li, W., Furth, E. E., Ciliberto, G., & Taub, R. (2000) · Hepatology · doi:10.1002/hep.510310123 · Cited by 298
Ikenaga, N., Peng, Z.-W., Vaid, K. A., Liu, S. B., Yoshida, S., Sverdlov, D. Y., Mikels-Vigdal, A., Smith, V., Schuppan, D., & Popov, Y. V. (2017) · Gut · doi:10.1136/gutjnl-2016-312473 · Cited by 295
Frangogiannis, N. G., Dewald, O., Xia, Y., Ren, G., Haudek, S., Leucker, T., Kraemer, D., Taffet, G., Rollins, B. J., & Entman, M. L. (2007) · Circulation · doi:10.1161/circulationaha.106.646091 · Cited by 289
Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets
Szabo, G., & Momen-Heravi, F. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.71 · Cited by 285
Raghu, G., Brown, K. K., Collard, H. R., Cottin, V., Gibson, K. F., Kaner, R. J., Lederer, D. J., Martinez, F. J., Noble, P. W., Song, J. W., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30421-0 · Cited by 278
Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases
Piera-Velazquez, S., Mendoza, F., & Jimenez, S. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5040045 · Cited by 273
Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment
Yang, J., Savvatis, K., Kang, J. S., Fan, P., Zhong, H., Schwartz, K., Barry, V., Mikels-Vigdal, A., Karpinski, S., Kornyeyev, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms13710 · Cited by 268
Weiskirchen, R., & Tacke, F. (2014) · PubMed · doi:10.3978/j.issn.2304-3881.2014.11.03 · Cited by 256
Self-citationArciniegas, E., Sutton, A. B., Allen, T. D., & Schor, A. M. (1992) · Journal of Cell Science · doi:10.1242/jcs.103.2.521 · Cited by 254
Critical comparison of elastography methods to assess chronic liver disease
Friedrich-Rust, M., Poynard, T., & Castera, L. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.86 · Cited by 245
Hepatic fibrosis and cirrhosis: The (myo)fibroblastic cell subpopulations involved
Guyot, C., Lepreux, S., Combe, C., Doudnikoff, E., Bioulac-Sage, P., Balabaud, C., & Desmoulière, A. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.08.021 · Cited by 243
Rygiel, K. A., Robertson, H., Marshall, H. L., Pekalski, M., Zhao, L., Booth, T. A., Jones, D. E. J., Burt, A. D., & Kirby, J. A. (2008) · Laboratory Investigation · doi:10.1038/labinvest.3700704 · Cited by 241
Transforming Growth Factor-β: Master Regulator of the Respiratory System in Health and Disease
Aschner, Y., & Downey, G. P. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0391tr · Cited by 237
The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis
Murtha, L. A., Schuliga, M. J., Mabotuwana, N. S., Hardy, S. A., Waters, D. W., Burgess, J. K., Knight, D. A., & Boyle, A. J. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00777 · Cited by 229
The balancing act of the liver: tissue regeneration versus fibrosis
Cordero-Espinoza, L., & Huch, M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93562 · Cited by 219
The role of the immune system in kidney disease
Tecklenborg, J., Clayton, D., Siebert, S., & Coley, S. M. (2018) · Clinical and Experimental Immunology · doi:10.1111/cei.13119 · Cited by 217
Hardy, T., Zeybel, M., Day, C. P., Dipper, C., Masson, S., McPherson, S., Henderson, E., Tiniakos, D., White, S., French, J., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-311526 · Cited by 216
Li, Y., Wang, J., & Asahina, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214136110 · Cited by 216
Scraping fibrosis: Expressway to the core of fibrosis
Mehal, W. Z., Iredale, J., & Friedman, S. L. (2011) · Nature Medicine · doi:10.1038/nm0511-552 · Cited by 211
Lan, T., Kisseleva, T., & Brenner, D. A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0129743 · Cited by 209
Tuchweber, B., Desmoulière, A., Bochaton‐Piallat, M., Rubbia‐Brandt, L., & Gabbiani, G. (1996) · PubMed · Cited by 205
Mechanisms of liver fibrosis resolution
Tacke, F., & Trautwein, C. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.039 · Cited by 205
Self-citationWhole-Exome Sequencing in Adults With Chronic Kidney Disease: A Pilot Study
Lata, S., Marasa, M., Li, Y., Fasel, D. A., Groopman, E., Jobanputra, V., Rasouly, H., Mitrotti, A., Westland, R., Verbitsky, M., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m17-1319 · Cited by 203
Menne, J., Eulberg, D., Beyer, D., Baumann, M., Saudek, F., Valkusz, Z., Więcek, A., Haller, H., & for the Emapticap Study Group (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv459 · Cited by 201
Kazlauskas, A. (2017) · Gene · doi:10.1016/j.gene.2017.03.003 · Cited by 200
Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis
Hirsova, P., & Gores, G. J. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2014.11.005 · Cited by 197
Myofibroblastic conversion of mesothelial cells
Yang, A. H., Chen, J. Y., & Lin, J. K. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00861.x · Cited by 190
Okuma, T., Terasaki, Y., Kaikita, K., Kobayashi, H., Kuziel, W. A., Kawasuji, M., & Takeya, M. (2004) · The Journal of Pathology · doi:10.1002/path.1667 · Cited by 189
Greenwel, P., Domínguez-Rosales, J.-A., Mavi, G., Rivas-Estilla, A. M., & Rojkind, M. (2000) · Hepatology · doi:10.1002/hep.510310118 · Cited by 189
Drug targeting to myofibroblasts: Implications for fibrosis and cancer
Yazdani, S., Bansal, R., & Prakash, J. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.010 · Cited by 189
Frantz, S., Falcao-Pires, I., Balligand, J.-L., Bauersachs, J., Brutsaert, D., Ciccarelli, M., Dawson, D., de Windt, L. J., Giacca, M., Hamdani, N., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1138 · Cited by 184
Extracellular vesicles in diagnosis and therapy of kidney diseases
Zhang, W., Zhou, X., Zhang, H., Yao, Q., Liu, Y., & Dong, Z. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00429.2016 · Cited by 179
The PDGF system and its antagonists in liver fibrosis
Borkham-Kamphorst, E., & Weiskirchen, R. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.10.002 · Cited by 177
Self-citationTherapeutic targets for treating fibrotic kidney diseases
Lee, S.-Y., Kim, S. I., & Choi, M. E. (2015) · Translational Research · doi:10.1016/j.trsl.2014.07.010 · Cited by 176
Raghu, G., Scholand, M. B., de Andrade, J., Lancaster, L., Mageto, Y., Goldin, J., Brown, K. K., Flaherty, K. R., Wencel, M., Wanger, J., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01030-2015 · Cited by 175
A Pneumocyte–Macrophage Paracrine Lipid Axis Drives the Lung toward Fibrosis
Romero, F., Shah, D., Duong, M., Penn, R. B., Fessler, M. B., Madenspacher, J., Stafstrom, W., Kavuru, M., Lu, B., Kallen, C. B., et al. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0343oc · Cited by 171
Regression of Existing Glomerulosclerosis by Inhibition of Aldosterone
Aldigier, J. C., Kanjanbuch, T., Ma, L.-J., Brown, N. J., & Fogo, A. B. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090804 · Cited by 171
Therapeutic targeting of liver inflammation and fibrosis by nanomedicine.
Bartneck, M., Warzecha, K. T., & Tacke, F. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2304-3881.2014.11.02 · Cited by 170
Self-citationTan, Y., Ge, G., Pan, T., Wen, D., & Gan, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105192 · Cited by 169
Treatment of Renal Fibrosis—Turning Challenges into Opportunities
Klinkhammer, B. M., Goldschmeding, R., Floege, J., & Boor, P. (2017) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2016.11.002 · Cited by 168
Liver Fibrosis: From Pathogenesis to Novel Therapies
Weiskirchen, R., & Tacke, F. (2016) · Digestive Diseases · doi:10.1159/000444556 · Cited by 167
Self-citationThe perivascular origin of pathological fibroblasts
Di Carlo, S. E., & Peduto, L. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93558 · Cited by 164
Fibrosis imaging: Current concepts and future directions
Baues, M., Dasgupta, A., Ehling, J., Prakash, J., Boor, P., Tacke, F., Kiessling, F. M., & Lammers, T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.10.013 · Cited by 164
Self-citationExtracellular Vesicles in Lung Disease
Kubo, H. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.06.026 · Cited by 163
Origins and functions of liver myofibroblasts
Lemoinne, S., Cadoret, A., Mourabit, H. E., Thabut, D., & Housset, C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.02.019 · Cited by 162
Pericytes as collagen-producing cells in excessive dermal scarring.
Sundberg, C., Ivarsson, M., Gerdin, B., & Rubin, K. (1996) · PubMed · Cited by 161
Human Fibrotic Diseases: Current Challenges in Fibrosis Research
Rosenbloom, J., Macarak, E., Piera-Velazquez, S., & Jimenez, S. A. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7113-8_1 · Cited by 158
Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats
Kinoshita, K., Iimuro, Y., Otogawa, K., Saika, S., Inagaki, Y., Nakajima, Y., Kawada, N., Fujimoto, J., Friedman, S., & Ikeda, K. (2006) · Gut · doi:10.1136/gut.2006.092460 · Cited by 153
Bleser, P. J. D., Xu, G., Rombouts, K., Rogiers, V., & Geerts, A. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.33881 · Cited by 151
Blood Biomarkers in Idiopathic Pulmonary Fibrosis
Guiot, J., Moermans, C., Henket, M., Corhay, J.-L., & Louis, R. (2017) · Lung · doi:10.1007/s00408-017-9993-5 · Cited by 147
Borkham‐Kamphorst, E., de Leur, E. V., Zimmermann, H. W., Karlmark, K. R., Tihaa, L., Haas, U., Tacke, F., Berger, T., Mak, T. W., & Weiskirchen, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.01.014 · Cited by 146
Self-citationNinichuk, V., Clauß, S., Kulkarni, O. P., Schmid, H., Segerer, S., Radomska, E., Eulberg, D., Buchner, K., Selve, N., Klußmann, S., et al. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070601 · Cited by 146
Nielsen, M. J., Veidal, S. S., Karsdal, M. A., Ørsnes‐Leeming, D. J., Vainer, B., Gardner, S. D., Hamatake, R. K., Goodman, Z. D., Schuppan, D., & Patel, K. (2014) · Liver International · doi:10.1111/liv.12700 · Cited by 144
Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment
Kaur, A., Mathai, S. K., & Schwartz, D. A. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00154 · Cited by 137
Molecular mechanisms involved in podocyte EMT and concomitant diabetic kidney diseases: an update
Ying, Q., & Wu, G. (2017) · Renal Failure · doi:10.1080/0886022x.2017.1313164 · Cited by 136
Interleukins in chronic liver disease: lessons learned from experimental mouse models
Tacke, F., & Hammerich, L. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s43737 · Cited by 135
Self-citationBiomarkers in idiopathic pulmonary fibrosis
Drakopanagiotakis, F., Wujak, L., Wygrecka, M., & Markart, P. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.01.023 · Cited by 132
Matricellular Protein CCN5 Reverses Established Cardiac Fibrosis
Jeong, D., Lee, M.-A., Li, Y., Yang, D. K., Kho, C., Oh, J. G., Hong, G., Lee, A., Song, M. H., LaRocca, T. J., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.030 · Cited by 132
Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis
Tacke, F. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1442436 · Cited by 130
Self-citationManea, S., Constantin, A. L., Manda, G., Sasson, S., & Manea, A. (2015) · Redox Biology · doi:10.1016/j.redox.2015.06.012 · Cited by 121
Mechanisms of alcoholic heart disease
Ren, J. T., & Wold, L. E. (2008) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944708095137 · Cited by 121
Biomarkers for the detection of renal fibrosis and prediction of renal outcomes: a systematic review
Mansour, S. G., Puthumana, J., Coca, S. G., Gentry, M., & Parikh, C. R. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0490-0 · Cited by 119
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step
Weiskirchen, R. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00303 · Cited by 117
Self-citationBorkham‐Kamphorst, E., Kovalenko, E., van Roeyen, C. R. C., Gaßler, N., Bomble, M., Ostendorf, T., Floege, J., Gressner, A. M., & Weiskirchen, R. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.71 · Cited by 111
Self-citationThe role of complement in the pathogenesis of renal ischemia-reperfusion injury and fibrosis
Danobeitia, J. S., Djamali, A., & Fernandez, L. A. (2014) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-7-16 · Cited by 107
Origin of Matrix-Producing Cells That Contribute to Aortic Fibrosis in Hypertension
Wu, J., Montaniel, K. R. C., Saleh, M. A., Xiao, L., Chen, W., Owens, G. K., Humphrey, J. D., Majesky, M. W., Paik, D. T., Hatzopoulos, A. K., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.06123 · Cited by 98
Pharmacological intervention in hepatic stellate cell activation and hepatic fibrosis
Schon, H.-T., Bartneck, M., Borkham-Kamphorst, E., Nattermann, J., Lammers, T., Tacke, F., & Weiskirchen, R. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00033 · Cited by 97
Self-citationXu, J., Gonzalez, E. T., Iyer, S. S., Mac, V., Mora, A. L., Sutliff, R. L., Reed, A., Brigham, K. L., Kelly, P., & Rojas, M. M. (2009) · The Journals of Gerontology Series A · doi:10.1093/gerona/glp040 · Cited by 95
IL-13 Signaling in Liver Fibrogenesis
Liu, Y., Munker, S., Müllenbach, R., & Weng, H. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00116 · Cited by 95
Svegliati‐Baroni, G., Inagaki, Y., Rincón‐Sánchez, A. R., Else, C., Saccomanno, S., Benedetti, A., Ramirez, F., & Rojkind, M. (2005) · Hepatology · doi:10.1002/hep.20798 · Cited by 87
Arias, M., Sauer-Lehnen, S., Treptau, J., Janoschek, N., Theuerkauf, I., Buettner, R., Gressner, A. M., & Weiskirchen, R. (2003) · BMC Gastroenterology · doi:10.1186/1471-230x-3-29 · Cited by 81
Self-citationReddy, A. T., Lakshmi, S. P., Zhang, Y., & Reddy, R. C. (2014) · The FASEB Journal · doi:10.1096/fj.14-256263 · Cited by 80
Pulmonary fibrosis in the era of stratified medicine
Mathai, S. K., Newton, C. A., Schwartz, D. A., & Garcia, C. K. (2016) · Thorax · doi:10.1136/thoraxjnl-2016-209172 · Cited by 77
Magnetic Resonance Imaging of the Fibrotic Kidney
Morrell, G., Zhang, J. L., & Lee, V. S. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016101089 · Cited by 75
Cardiac MR Imaging of Hypertrophic Cardiomyopathy: Techniques, Findings, and Clinical Relevance
Amano, Y., Kitamura, M., Takano, H., Yanagisawa, F., Tachi, M., Suzuki, Y., Kumita, S., & Takayama, M. (2018) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.rev.2017-0145 · Cited by 75
Genetic factors and systemic sclerosis
Murdaca, G., Contatore, M., Gulli, R., Mandich, P., & Puppo, F. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.01.016 · Cited by 74
Iwayama, T., & Olson, L. E. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-012-0304-0 · Cited by 70
Douillet, C., Velarde, V., Christopher, J., Mayfield, R. K., Trojanowska, M., & Jaffa, A. A. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.6.h2829 · Cited by 70
Targeting the Chemokines in Cardiac Repair
Cavalera, M., & Frangogiannis, N. G. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990449 · Cited by 69
BMP-7 counteracting TGF-beta1 activities in organ fibrosis
Weiskirchen, R. (2013) · Frontiers in bioscience · doi:10.2741/4189 · Cited by 65
Self-citationMeurer, S. K., Lahme, B., Tihaa, L., Weiskirchen, R., & Gressner, A. M. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.07.001 · Cited by 65
Self-citationThe role of PDGF-D in healthy and fibrotic kidneys
Buhl, E. M., Djudjaj, S., Bábíčková, J., Klinkhammer, B. M., Folestad, E. B., Borkham‐Kamphorst, E., Weiskirchen, R., Hudkins, K. L., Alpers, C. E., Eriksson, U., et al. (2016) · Kidney International · doi:10.1016/j.kint.2015.12.037 · Cited by 63
Self-citationPhenotypic change in portal fibroblasts in biliary fibrosis
Tang, L., Tanaka, Y., Marumo, F., & Sato, C. (1994) · Liver International · doi:10.1111/j.1600-0676.1994.tb00051.x · Cited by 62
Martin, I. V., Borkham‐Kamphorst, E., Zok, S., van Roeyen, C. R. C., Eriksson, U., Boor, P., Hittatiya, K., Fischer, H., Wasmuth, H. E., Weiskirchen, R., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.09.006 · Cited by 60
Self-citationp47phox contributes to albuminuria and kidney fibrosis in mice
Wang, H., Chen, X., Su, Y. R., Paueksakon, P., Hu, W., Zhang, M., Harris, R. C., Blackwell, T. S., Zent, R., & Pozzi, A. (2015) · Kidney International · doi:10.1038/ki.2014.386 · Cited by 58
Targeting platelet-derived growth factor as a therapeutic approach in pulmonary fibrosis
Nishioka, Y., Azuma, M., Kishi, M., & Aono, Y. (2013) · The Journal of Medical Investigation · doi:10.2152/jmi.60.175 · Cited by 57
Tománková, T., Kriegová, E., & Liu, M. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00203.2014 · Cited by 55
Molecular mechanisms of atrial fibrosis: implications for the clinic
Thanigaimani, S., Lau, D. H., Agbaedeng, T. A., Elliott, A. D., Mahajan, R., & Sanders, P. (2017) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2017.1299005 · Cited by 55
Connective tissue growth factor is induced in bleomycin‐induced skin scleroderma
Liu, S., Taghavi, R., & Leask, A. (2009) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-009-0081-3 · Cited by 53
Effects of interleukin-33 on cardiac fibroblast gene expression and activity
Zhu, J., & Carver, W. E. (2012) · Cytokine · doi:10.1016/j.cyto.2012.02.008 · Cited by 51
Elevated circulating fibrocyte levels in patients with hypertensive heart disease
Keeley, E. C., Mehrad, B., Janardhanan, R., Salerno, M., Hunter, J. R., Burdick, M., Field, J. J., Strieter, R. M., & Kramer, C. M. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835639bb · Cited by 50
Leukocyte Trafficking in Cardiovascular Disease: Insights from Experimental Models
Jones, D., True, H. D., & Patel, J. (2017) · Mediators of Inflammation · doi:10.1155/2017/9746169 · Cited by 48
Wu, L., Luo, Z., Zheng, J., Yao, P., Yuan, Z., Lv, X., Zhao, J., & Wang, M. (2018) · Inflammation · doi:10.1007/s10753-018-0742-6 · Cited by 48
Interleukin-33 in the pathogenesis of liver fibrosis: alarming ILC2 and hepatic stellate cells
Weiskirchen, R., & Tacke, F. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.62 · Cited by 47
Self-citationZaffanello, M., Tardivo, S., Cataldi, L., Fanos, V., Biban, P., & Malerba, G. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1695-7 · Cited by 44
Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential
Raghu, G. (2017) · European Respiratory Review · doi:10.1183/16000617.0071-2017 · Cited by 44
Murphy‐Marshman, H., Quensel, K., Shiwen, X., Barnfield, R., Kelly, J., Peidl, A., Stratton, R. J., & Leask, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186740 · Cited by 42
Ohkubo, H., Nakagawa, H., & Niimi, A. (2017) · Respiratory Investigation · doi:10.1016/j.resinv.2017.10.003 · Cited by 42
Distinct sites of renal fibrosis in Crim1 mutant mice arise from multiple cellular origins
Phua, Y. L., Martel, N., Pennisi, D. J., Little, M. H., & Wilkinson, L. J. (2012) · The Journal of Pathology · doi:10.1002/path.4155 · Cited by 41
Iqbal, S. A., Sidgwick, G. P., & Bayat, A. (2012) · Archives of Dermatological Research · doi:10.1007/s00403-012-1225-5 · Cited by 40
Can a fibrotic liver afford epithelial-mesenchymal transition?
Munker, S., Wu, Y., Ding, H.-G., Liebe, R., & Weng, H. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i26.4661 · Cited by 39
Ultrastructural observations on sinusoidal endothelial cells in chronic active hepatitis
Bardadin, K. A., & Desmet, V. J. (1985) · Histopathology · doi:10.1111/j.1365-2559.1985.tb02433.x · Cited by 38
Reyes‐Gordillo, K., Shah, R., Arellanes‐Robledo, J., Nazará, Z., Rincón‐Sánchez, A. R., Inagaki, Y., Rojkind, M., & Lakshman, M. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.01.020 · Cited by 34
Mäkelä, K., Hodgson, U., Piilonen, A. K., Kelloniemi, K., Bloigu, R., Sutinen, E., Salmenkivi, K., Rönty, M. J., Lappi‐Blanco, E., Myllärniemi, M., et al. (2018) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001031 · Cited by 26
Functional Role of Cardiovascular Exosomes in Myocardial Injury and Atherosclerosis
Vanhaverbeke, M., Gal, D., & Holvoet, P. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4397-0_3 · Cited by 25
Cellular Therapeutics for Heart Failure: Focus on Mesenchymal Stem Cells
Pandey, A. C., Lancaster, J. J., Harris, D. T., Goldman, S., & Juneman, E. B. (2017) · Stem Cells International · doi:10.1155/2017/9640108 · Cited by 24
Genetics in liver disease: new concepts
Zimmer, V., & Lammert, F. (2011) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283444862 · Cited by 23
Culture Model of Rat Portal Myofibroblasts
Mourabit, H. E., Loeuillard, E. J., Lemoinne, S., Cadoret, A., & Housset, C. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00120 · Cited by 18
Cell-Based Therapies for Tissue Fibrosis
Lim, R., Ricardo, S. D., & Sievert, W. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00633 · Cited by 18
Non-coding RNAs in cardiac fibrosis: emerging biomarkers and therapeutic targets
Chen, Z., Li, C., Lin, K., Cai, H., Ruan, W., Han, J., & Rao, L. (2013) · Cardiology Journal · doi:10.5603/cj.a2017.0153 · Cited by 10
Cited by
Ferulic acid: A review of its pharmacology, pharmacokinetics and derivatives
Li, D., Rui, Y.-X., Guo, S.-D., Luan, F., Liu, R., & Zeng, N. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119921 · Cited by 506
López-Otín, C., & Kroemer, G. (2021) · Cell · doi:10.1016/j.cell.2020.11.034 · Cited by 499
Marconi, G. D., Fonticoli, L., Rajan, T. S., Pierdomenico, S. D., Trubiani, O., Pizzicannella, J., & Diomede, F. (2021) · Cells · doi:10.3390/cells10071587 · Cited by 410
Autophagy in liver diseases: A review
Qian, H., Chao, X., Williams, J., Fulte, S., Li, T., Yang, L., & Ding, W.-X. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100973 · Cited by 373
Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences
Panizo, S., Martínez-Arias, L., Alonso-Montes, C., Cannata, P., Martín-Carro, B., Fernández-Martín, J. L., Naves-Díaz, M., Carrillo-López, N., & Cannata-Andía, J. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010408 · Cited by 372
Metadata
- Authors
- Weiskirchen, R., Weiskirchen, S., & Tacke, F.
- Venue
- Molecular Aspects of Medicine
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 65
- Pages
- 2-15
- ISSN
- 0098-2997 (ISSN-L)
- OpenAlex
- W2811001233
- Cited by
- 538
- References
- 190
- FWCI
- 26.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.